Participant guide
How studies are reviewed and monitored
Before any colorectal cancer study can enroll you, an independent committee must review it. That review does not end once the study begins.
Updated
Independent review
The reviewing committee has a name: Institutional Review Board, shortened to IRB. Its members are independent from the research team. Two things get checked before a colorectal cancer study starts, the study plan and the consent document, and the same board keeps checking for as long as the study runs. All of this exists to protect your rights and welfare as someone taking part.
Who runs colorectal cancer studies
As of November 16, 2026, 525 colorectal cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (294), industry (208), government (23). The sponsor is the organization responsible for a study.
See which colorectal cancer studies are recruiting near you.
Federal rules
In the United States, research has to follow federal regulations. Those rules spell out the information you must be given and the protections you are owed when you take part. A colorectal cancer study that tests a medication or a device answers to a second authority too: the U.S. Food and Drug Administration.
Monitoring during the study
During a study, you see the study team at scheduled visits, where they follow your health and record any problems you tell them about. A serious concern can lead to a study being changed, paused, or stopped.
Be clear on what oversight does. It lowers risk without removing it. Risks come with every study, and the known ones are described in the consent document.
Talk with a study coordinator
Call (888) 385-9581, or send us the short form if you prefer. A coordinator will tell you which colorectal cancer studies may fit and what happens next. You are not committing to anything by asking questions.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services